Arbutus Biopharma Corp (NASDAQ:ABUS)

3.10
Delayed Data
As of 3:59pm ET
 +0.30 / +10.71%
Today’s Change
0.82
Today|||52-Week Range
4.75
+11.51%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Arbutus Biopharma Corp have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 1.50. The median estimate represents a +93.55% increase from the last price of 3.10.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Arbutus Biopharma Corp. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.34
Sales
$1.4M
Reporting Date
Mar 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 77.17%
 
 
 
 
 
 
Growthannually -122.93%
 
 
 
 
 
 

Sales

Growthquarterly -54.15%
 
 
 
 
 
 
Growthannually 107.67%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.